A total of 41 patients (including 8 patients in the placebo group and 33 patients in the HSK21542 group) were analyzed for safety and their serum prolactin concentrations, and 33 in the HSK21542 group were included in the PKS. The gene discussed is PRL; the disease is tetrasomy 12p.